Screener
Syndax Pharmaceuticals SNDX Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Syndax Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 4:04 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-197154
FAQ
- What is Syndax Pharmaceuticals's net margin?
- Syndax Pharmaceuticals (SNDX) reported net margin of -111.9% in Q1 2026.
- How has Syndax Pharmaceuticals's net margin changed year-over-year?
- Syndax Pharmaceuticals's net margin increased by 85.2% year-over-year, from -757.5% to -111.9%.
- What is the long-term trend for Syndax Pharmaceuticals's net margin?
- Over 3 years (2020 to 2025), Syndax Pharmaceuticals's net margin has grown at a -67.5% compound annual growth rate (CAGR), from -4,822.5% to -165.4%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Syndax Pharmaceuticals's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude